FLUCONAZOLE AND BORIC ACID FOR TREATMENT OF VAGINAL CANDIDIASIS--NEW WORDS ABOUT OLD ISSUE

East Afr Med J. 2013 Apr;90(4):117-23.

Abstract

Objective: To compare boric acid as an effective treatment for VVC compared to fluconazole. We also studied the efficiency of these drugs in preventing recurrence of VVC.

Design: A cross sectional, randomized, double-blind study.

Settings: Gynaecology clinic of Imam Reza hospital, Tehran - Iran

Subjects: Women with signs and symptoms related to Vulvo Vaginal Candidiasis.

Results: Seventy five patients out of total 150 patients with signs and symptoms related to Vulvo Vaginal Candidiasis were treatedwith boric acidpowder everynight for a week and the remaining 75 patients received Fluconazole. The cure rate in first group was 46.7% but the cure rate in second group was 37.3%. The difference was not statistically significant (P>0.3). Difference between the efficacy of the two drugs was not significant either (P=0.47). The recurrence rate among patients in first group was 35% while it was 32% in second group. Their difference was not statistically significant (P=0.54).

Conclusion: According to our findings, treatment of vaginal candidiasis with boric acid is as effective as fluconazole. The availability of boric acid and its relatively low cost suggests it as a safe and effective drug for treatment of candidiasis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Intravaginal
  • Administration, Oral
  • Adult
  • Antifungal Agents / administration & dosage
  • Boric Acids / administration & dosage*
  • Candida* / drug effects
  • Candida* / isolation & purification
  • Candidiasis, Vulvovaginal* / diagnosis
  • Candidiasis, Vulvovaginal* / drug therapy
  • Candidiasis, Vulvovaginal* / physiopathology
  • Double-Blind Method
  • Female
  • Fluconazole / administration & dosage*
  • Humans
  • Iran
  • Secondary Prevention / methods
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Boric Acids
  • Fluconazole
  • boric acid